AZ's asthma and diabetes drugs get label boosts in EU

Two of AstraZeneca’s most important drugs have received a boost, after European regulators backed a pen allowing people to inject themselves with respiratory drug Fasenra, and agreed that c

Sanofi/Regeneron asthma trial casts doubt on IL-33 class pro...

Registration is Live for the Inaugural Respiratory Drug Deli...

Registration is Live for the Inaugural Respiratory Drug

Propeller Health: respiring for success

David Van Sickle is on a mission to transform treatment for respiratory diseases with the company he co-founded, Propeller Health.

Novartis builds case for asthma drugs to challenge GSK

Novartis has positive data for a two-drug asthma regimen that forms the backbone of its efforts to take on rival GlaxoSmithKline in the respiratory market.

EU regulators accept Novartis' triple asthma combo

European regulators have accepted Novartis’ filing for a triple combination therapy for asthma known as QVM149, triggering payments to development partners Vectura and Sosei.